Concepedia

Author

Titouan Cazaubiel

Centre Hospitalier Régional et Universitaire de Nancy

Also Known As

Cyril Melot, T Cazaubiel, T. Cazaubiel, Titouan Cazaubiel

34

Publications

603

Citations

13

H-Index

12

Concepts

All Affiliations

Centre Hospitalier Régional et Universitaire de NancyCentre Hospitalier Annecy GenevoisUniversité de Caen NormandieInstitut universitaire du cancer de Toulouse OncopoleHôpital Saint-Antoine
TC

About

Titouan Cazaubiel is an author at Centre Hospitalier Régional et Universitaire de Nancy specializing in medicine, oncology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

34

2

Health Sciences

1

1

17

3

Immunology

1

1

17

4

Pathology

1

1

17

5

Surgical Oncology

1

1

17

Titouan Cazaubiel

×

10

Publications

438

Citations

10

H-Index

YearCitations

Early Versus Late Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma: Long-Term Follow-up Analysis of the IFM 2009 Trial

Aurore Perrot, Valérie Lauwers‐Cancès, Titouan Cazaubiel,

Blood

2020

118

RG6234, a GPRC5DxCD3 T-Cell Engaging Bispecific Antibody, Is Highly Active in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Intravenous (IV) and First Subcutaneous (SC) Results from a Phase I Dose-Escalation Study

Carmelo Carlo‐Stella, Rita Mazza, Salomon Manier,

Blood

2022

86

Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor

Anaïs Schavgoulidze, Alexis Talbot, Aurore Perrot,

Blood

2022

54

Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study

Aurélie Jourdes, Elise Cellerin, Cyrille Touzeau,

Clinical Microbiology and Infection

2024

46

In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations

Romain Lannes, Mehmet Samur, Aurore Perrot,

Journal of Clinical Oncology

2022

43

Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical features

Titouan Cazaubiel, Xavier Leleu, Aurore Perrot,

Blood

2022

27

Reduce Mortality and Morbidity in Acute Myeloid Leukemia With Hyperleukocytosis With Early Admission in Intensive Care Unit: A Retrospective Analysis

Nathan Mottal, Nahéma Issa, Pierre‐Yves Dumas,

Journal of Hematology

2020

19

Heterogeneity in long-term outcomes for patients with Revised International Staging System stage II, newly diagnosed multiple myeloma

Anaïs Schavgoulidze, Valérie Lauwers‐Cancès, Aurore Perrot,

Haematologica

2022

17

OA-05 Efficacy of forimtamig, a GPRC5DxCD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM): analysis of patient and disease-related factors associated with responses

Simon J. Harrison, Caroline Hasselbalch Riley, Salomon Manier,

Clinical Lymphoma Myeloma & Leukemia

2023

17

<i>RAS/RAF</i> landscape in monoclonal plasma cell conditions

Anaïs Schavgoulidze, Jill Corre, Mehmet Samur,

Blood

2024

11

Page 1